Relationship between periodontal status and selected clinical characteristics in type 2 diabetic patients

Abbas, Dalia Kudier

doi:10.32828/mdj.v6i3.473

Cited by 1 publication

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The subjects encompassed in the existing study were the control group with healthy periodontium exhibiting a PPD of ≤3 mm, BOP of ≤10%, and intact periodontium, while the periodontitis groups were defined as the presence of interdental CAL at ≥2 nonadjacent teeth or buccal or oral CAL ≥ 3 mm with the presence of pocket depth > 3 mm, which is detectable at ≥2 teeth [ 26 ]. Besides, all periodontitis cases exhibited a generalized form (≥30% of teeth involved) and unstable status (PPD ≥ 5 mm or PPD 4 mm with BOP) [ 37 ].…”

Section: Methodsmentioning

confidence: 99%

“…Studies have demonstrated that smoking is associated with increased susceptibility to periodontal disease, with a probability of up to sevenfold higher than individuals who do not smoke [22][23][24][25]. Moreover, research indicates that smoker individuals exhibit more severe periodontal destruction than nonsmokers [26][27][28][29][30][31]. This relationship is dose-dependent, with the severity of destruction being linked to the number of cigarettes smoked and the duration of smoking [30,[32][33][34].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Antimicrobial Peptide LL‐37 as a Predictor Biomarker for Periodontitis with the Presence and Absence of Smoking: A Case‐Control Study

Kzar,

Abbas,

Hussein

2023

BioMed Research International

View full text Add to dashboard Cite

Background. A major issue is finding a valid biomarker able to diagnose periodontal disease with the presence and absence of risk factors. Indeed, the association between smoking and periodontal diseases and its impact on the manifestation of antimicrobial peptides has been delineated in clinical and epidemiological investigations. The antimicrobial peptide cathelicidin (LL-37) is pivotal in preserving periodontal health. Objectives. This investigation examines and contrasts the levels of cathelicidin in the saliva of smokers and nonsmokers of periodontitis. The study also seeks to establish this biomarker’s diagnostic ability to differentiate between periodontal health and disease. Materials and Methods. The study involved the collection of unstimulated saliva samples from 160 participants, comprising 80 patients diagnosed with periodontitis (40 of whom were smokers and 40 were nonsmokers) and 80 periodontitis-free individuals (40 smokers and 40 nonsmokers). The clinical periodontal parameters were assessed, including recording the probing pocket depth, the level of clinical attachment, and the percentage of bleeding on probing. Subsequently, enzyme-linked immunosorbent assays were conducted to quantify the protein levels of LL-37 in the saliva samples obtained from the subjects mentioned above. Results. The highest level of salivary LL-37 was found in the nonsmoker periodontitis (NSP) patients, followed by the group of smoker periodontitis (SP) and then nonsmoker healthy (NSH) group, while the lowest level was found in the healthy smoker (HS) group. At the same time, the LL-37 seems to be a very good biomarker in differentiating periodontal health from disease with the presence and absence of smoking. Conclusion. Periodontitis results in a significant elevation of salivary LL-37 levels in smoker and nonsmoker patients compared to healthy individuals. These levels are positively correlated with the periodontal parameter and can serve as a valuable diagnostic tool to predict periodontitis, whereas smoking significantly reduces these levels.

show abstract

Section: Methodsmentioning

confidence: 99%